主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Zhang Kunrong Gu Sai
英文单位:Department of Gastroenterology the First Affiliated Hospital of Chongqing Medical University Chongqing 400016 China
英文关键词:Irritablebowelsyndrome;Non-drugtherapy;Medication
便秘型肠易激综合征(IBS-C)是肠易激综合征中的一种亚型,由于其发病机制尚不十分明确,因此在治疗方面尚无特异性方法,主要是以缓泻剂治疗,但它在完全缓解症状及预防复发上难以达到满意的疗效。近年来,不断研发新的药物和持续更新相关临床指南使IBS-C的诊疗得到了进一步的发展。基于此,本综述着重总结了当前治疗IBS-C的研究进展,以期为临床实践提供依据及支持。
Irritable bowel syndrome with constipation (IBS-C) is a subtype of irritable bowel syndrome (IBS). Because its exact pathogenesis is not clear, there is no specific method in terms of treatment, mainly based on laxatives, but it is difficult to achieve satisfactory efficacy in completely relieving symptoms and preventing recurrence. In recent years, the continuous development of new drugs and the update of relevant clinical guidelines have further developed the diagnosis and treatment of IBS-C. Based on this, this review focuses on the current research progress in the treatment of IBS-C, in order to provide evidence and support for clinical practice.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。